Same Indication

Pembrolizumab vs Telmisartan

Pembrolizumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Telmisartan.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Telmisartan — 24 hours.

Chemical Properties

Molecular Formula: Telmisartan — C33H30N4O2.

Molecular Weight: Telmisartan — 514.6230 g/mol.

Type: Pembrolizumab — Antibody; Telmisartan — Small molecule.